Possibilities of combined hypolipidemic therapy in different categories of high and very high cardiovascular risk patients (a pilot study)
Aim of the study was to evaluate the efficacy and safety of the combined use of statins with ezetimibe in patients of various nosological groups of high and very high cardiovascular risk. Material and methods. A prospective interventional non-randomized study included 40 people, mean age 60.7±9.5 ye...
Main Authors: | Oksana V. Tsygankova, Olga V. Timoshchenko, Lyudmila D. Latyntseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
2022-01-01
|
Series: | Атеросклероз |
Subjects: | |
Online Access: | https://ateroskleroz.elpub.ru/jour/article/view/546/490 |
Similar Items
-
THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01) -
From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01) -
The tangled web of dyslipidemia and cancer: Is there any association?
by: Sina Neshat, et al.
Published: (2022-01-01) -
Effect of pitavastatin on levels and functions of HDL-C in patients with stable coronary artery disease and dyslipidemia
by: WANG Hui-juan, WANG Ji-hong, ZHAO Xing-shan, LIU Wei
Published: (2022-03-01) -
Low Cholesterol Levels in Younger Heart Failure Patients May Predict Unfavorable Outcomes
by: Lior Charach, et al.
Published: (2023-07-01)